Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant.

Maretti E, Rustichelli C, Lassinantti Gualtieri M, Costantino L, Siligardi C, Miselli P, Buttini F, Montecchi M, Leo E, Truzzi E, Iannuccelli V.

Pharmaceutics. 2019 Oct 1;11(10). pii: E508. doi: 10.3390/pharmaceutics11100508.

2.

Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.

Calogiuri G, Garvey LH, Nettis E, Romita P, Di Leo E, Caruso R, Butani L, Foti C.

Recent Pat Inflamm Allergy Drug Discov. 2019 Sep 19. doi: 10.2174/1872213X13666190919162414. [Epub ahead of print]

PMID:
31538908
3.

Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.

Dalpiaz A, Fogagnolo M, Ferraro L, Beggiato S, Hanuskova M, Maretti E, Sacchetti F, Leo E, Pavan B.

Eur J Pharm Biopharm. 2019 Sep 12. pii: S0939-6411(19)30051-7. doi: 10.1016/j.ejpb.2019.09.008. [Epub ahead of print]

PMID:
31521715
4.

Polyethylene glycols and polysorbates: Two still neglected ingredients causing true IgE-mediated reactions.

Calogiuri G, Foti C, Nettis E, Di Leo E, Macchia L, Vacca A.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2509-2510. doi: 10.1016/j.jaip.2019.05.058. No abstract available.

PMID:
31495440
5.

Novel mutations of SAR1B gene in four children with chylomicron retention disease.

Simone ML, Rabacchi C, Kuloglu Z, Kansu A, Ensari A, Demir AM, Hizal G, Di Leo E, Bertolini S, Calandra S, Tarugi P.

J Clin Lipidol. 2019 Jul - Aug;13(4):554-562. doi: 10.1016/j.jacl.2019.05.013. Epub 2019 May 30.

PMID:
31253576
6.

Omalizumab For The Treatment of Persistent Drug Induced Urticaria Elicited By Thienopyridines: A Case Report.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG.

Antiinflamm Antiallergy Agents Med Chem. 2019 May 21. doi: 10.2174/1871523018666190522105055. [Epub ahead of print]

PMID:
31113348
7.

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours.

Ordonez LD, Hay T, McEwen R, Polanska UM, Hughes A, Delpuech O, Cadogan E, Powell S, Dry J, Tornillo G, Silcock L, Leo E, O'Connor MJ, Clarke AR, Smalley MJ.

Oncotarget. 2019 Apr 5;10(27):2586-2606. doi: 10.18632/oncotarget.26830. eCollection 2019 Apr 5.

8.

Distal Extended Endovascular Aortic Repair PETTICOAT: A Modified Technique to Improve False Lumen Remodeling in Acute Type B Aortic Dissection.

Molinari AC, Leo E, Ferraresi M, Ferrari SA, Terzi A, Sommaruga S, Rossi G.

Ann Vasc Surg. 2019 Aug;59:300-305. doi: 10.1016/j.avsg.2019.02.053. Epub 2019 May 7.

PMID:
31075476
9.

Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease.

Chaparro M, Garre A, Guerra Veloz MF, Vázquez JM, De Castro ML, Leo E, Rodriguez E, Carbajo AY, Riestra S, Jiménez I, Calvet X, Bujanda L, Rivero M, Gomollón F, Benítez JM, Bermejo F, Alcaide N, Gutiérrez A, Mañosa M, Iborra M, Lorente R, Rojas-Feria M, Barreiro-de Acosta M, Kolle L, Van Domselaar M, Amo V, Argüelles F, Ramírez E, Morell A, Bernardo D, Gisbert JP.

J Crohns Colitis. 2019 Apr 12. pii: jjz070. doi: 10.1093/ecco-jcc/jjz070. [Epub ahead of print]

PMID:
30976785
10.

The effects of hyperglycemia on outcomes in surgical high-grade glioma patients.

Decker M, Sacks P, Abbatematteo J, De Leo E, Brennan M, Rahman M.

Clin Neurol Neurosurg. 2019 Apr;179:9-13. doi: 10.1016/j.clineuro.2019.02.011. Epub 2019 Feb 11.

PMID:
30784896
11.

Idiopathic nonhistaminergic angioedema: A single-center real-life experience from Italy.

Nettis E, Di Leo E, Racanelli V, Macchia L, Vacca A.

Allergy. 2019 Jul;74(7):1389-1392. doi: 10.1111/all.13737. Epub 2019 Mar 3. No abstract available.

PMID:
30740715
12.

Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation.

Truzzi E, Meneghetti F, Mori M, Costantino L, Iannuccelli V, Maretti E, Domenici F, Castellano C, Rogers S, Capocefalo A, Leo E.

J Colloid Interface Sci. 2019 Apr 1;541:399-406. doi: 10.1016/j.jcis.2019.01.094. Epub 2019 Jan 23.

PMID:
30710822
13.

Self-assembled organogelators as artificial stratum corneum models: Key-role parameters for skin permeation prediction.

Maretti E, Rustichelli C, Miselli P, Leo E, Truzzi E, Iannuccelli V.

Int J Pharm. 2019 Feb 25;557:314-328. doi: 10.1016/j.ijpharm.2018.12.071. Epub 2018 Dec 30.

PMID:
30599224
14.

Should succinate esters be considered excipients in systemic corticosteroid allergy?

Calogiuri G, Foti C, Nettis E, Di Leo E, Macchia L, Vacca A.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):342-343. doi: 10.1016/j.jaip.2018.10.047. No abstract available.

PMID:
30598184
15.

Successful treatment of four types of chronic urticaria with anti-IgE omalizumab in the same patient.

Nettis E, Di Leo E, Calogiuri G, Foti C, Macchia L.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):336-337. doi: 10.1016/j.anai.2018.12.002. Epub 2018 Dec 7. No abstract available.

PMID:
30529714
16.

Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.

Maretti E, Costantino L, Buttini F, Rustichelli C, Leo E, Truzzi E, Iannuccelli V.

Drug Deliv Transl Res. 2019 Feb;9(1):298-310. doi: 10.1007/s13346-018-00607-w.

PMID:
30484257
17.

Focus on the role of substance P in chronic urticaria.

Vena GA, Cassano N, Di Leo E, Calogiuri GF, Nettis E.

Clin Mol Allergy. 2018 Nov 19;16:24. doi: 10.1186/s12948-018-0101-z. eCollection 2018. Review.

18.

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.

McCoull W, Cheung T, Anderson E, Barton P, Burgess J, Byth K, Cao Q, Castaldi MP, Chen H, Chiarparin E, Carbajo RJ, Code E, Cowan S, Davey PR, Ferguson AD, Fillery S, Fuller NO, Gao N, Hargreaves D, Howard MR, Hu J, Kawatkar A, Kemmitt PD, Leo E, Molina DM, O'Connell N, Petteruti P, Rasmusson T, Raubo P, Rawlins PB, Ricchiuto P, Robb GR, Schenone M, Waring MJ, Zinda M, Fawell S, Wilson DM.

ACS Chem Biol. 2018 Nov 16;13(11):3131-3141. doi: 10.1021/acschembio.8b00698. Epub 2018 Oct 17.

PMID:
30335946
19.

Impact of Ocean Acidification and Warming on the bioenergetics of developing eggs of Atlantic herring Clupea harengus.

Leo E, Dahlke FT, Storch D, Pörtner HO, Mark FC.

Conserv Physiol. 2018 Sep 18;6(1):coy050. doi: 10.1093/conphys/coy050. eCollection 2018.

20.

pH-Promoted Release of a Novel Anti-Tumour Peptide by "Stealth" Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells.

Sacchetti F, Marverti G, D'Arca D, Severi L, Maretti E, Iannuccelli V, Pacifico S, Ponterini G, Costi MP, Leo E.

Pharm Res. 2018 Sep 12;35(11):206. doi: 10.1007/s11095-018-2489-z.

PMID:
30209680
21.

Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors.

Lualdi M, Cavalleri A, Battaglia L, Colombo A, Garrone G, Morelli D, Pignoli E, Sottotetti E, Leo E.

BMC Cancer. 2018 Aug 22;18(1):841. doi: 10.1186/s12885-018-4754-2.

22.

Latex Allergy and Occupational Exposure: The Patient's Perspective.

Baiardini I, Di Leo E, Molinengo G, Braido F, Canonica GW, Nettis E.

J Investig Allergol Clin Immunol. 2018 Aug;28(4):269-271. doi: 10.18176/jiaci.0257. No abstract available.

23.

Focus on the agents most frequently responsible for perioperative anaphylaxis.

Di Leo E, Delle Donne P, Calogiuri GF, Macchia L, Nettis E.

Clin Mol Allergy. 2018 Jul 9;16:16. doi: 10.1186/s12948-018-0094-7. eCollection 2018. Review.

24.

Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.

Nettis E, Cegolon L, Di Leo E, Lodi Rizzini F, Detoraki A, Canonica GW; Italian OCUReL study group.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):474-478. doi: 10.1016/j.anai.2018.06.014. Epub 2018 Jun 24. Erratum in: Ann Allergy Asthma Immunol. 2018 Dec;121(6):749.

PMID:
29949781
25.

Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex-induced contact urticaria.

Di Leo E, Calogiuri G, Macchia L, Nettis E.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):300-302. doi: 10.1016/j.jaip.2018.05.005. Epub 2018 May 23. No abstract available.

PMID:
29802908
26.

Chiral Light Design and Detection Inspired by Optical Antenna Theory.

Poulikakos LV, Thureja P, Stollmann A, De Leo E, Norris DJ.

Nano Lett. 2018 Aug 8;18(8):4633-4640. doi: 10.1021/acs.nanolett.8b00083. Epub 2018 Mar 23.

27.

Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.

Nettis E, Cegolon L, Di Leo E, Canonica WG, Detoraki A; Italian OCUReL Study Group.

Ann Allergy Asthma Immunol. 2018 Mar;120(3):318-323. doi: 10.1016/j.anai.2017.12.007.

PMID:
29508719
28.

A favorable response to omalizumab in a patient with cheilitis granulomatosa.

Nettis E, Di Leo E, Bisaccia M, Marasco C, Foti C, Vacca A.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1425-1426. doi: 10.1016/j.jaip.2017.12.013. Epub 2018 Feb 6. No abstract available.

PMID:
29426753
29.

SLFN11 Blocks Stressed Replication Forks Independently of ATR.

Murai J, Tang SW, Leo E, Baechler SA, Redon CE, Zhang H, Al Abo M, Rajapakse VN, Nakamura E, Jenkins LMM, Aladjem MI, Pommier Y.

Mol Cell. 2018 Feb 1;69(3):371-384.e6. doi: 10.1016/j.molcel.2018.01.012.

30.

Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.

Nettis E, Cegolon L, Macchia L, Zaza I, Calogiuri G, Di Leo E.

Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886. No abstract available.

31.

Colloidal-Quantum-Dot Ring Lasers with Active Color Control.

le Feber B, Prins F, De Leo E, Rabouw FT, Norris DJ.

Nano Lett. 2018 Feb 14;18(2):1028-1034. doi: 10.1021/acs.nanolett.7b04495. Epub 2018 Jan 8.

32.

Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.

Nettis E, Di Leo E, Foti C, Cegolon L, Vacca A.

J Am Acad Dermatol. 2018 Jun;78(6):1211-1213. doi: 10.1016/j.jaad.2017.11.047. Epub 2017 Dec 5. No abstract available.

PMID:
29203434
33.

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.

Pfeiffer N, Voykov B, Renieri G, Bell K, Richter P, Weigel M, Thieme H, Wilhelm B, Lorenz K, Feindor M, Wosikowski K, Janicot M, Päckert D, Römmich R, Mala C, Fettes P, Leo E.

PLoS One. 2017 Nov 30;12(11):e0188899. doi: 10.1371/journal.pone.0188899. eCollection 2017.

34.

Polarization Multiplexing of Fluorescent Emission Using Multiresonant Plasmonic Antennas.

De Leo E, Cocina A, Tiwari P, Poulikakos LV, Marqués-Gallego P, le Feber B, Norris DJ, Prins F.

ACS Nano. 2017 Dec 26;11(12):12167-12173. doi: 10.1021/acsnano.7b05269. Epub 2017 Nov 30.

35.

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer.

Ballestrero A, Bedognetti D, Ferraioli D, Franceschelli P, Labidi-Galy SI, Leo E, Murai J, Pommier Y, Tsantoulis P, Vellone VG, Zoppoli G.

J Transl Med. 2017 Oct 2;15(1):199. doi: 10.1186/s12967-017-1296-3.

36.

Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.

Di Costanzo A, Di Leo E, Noto D, Cefalù AB, Minicocci I, Polito L, D'Erasmo L, Cantisani V, Spina R, Tarugi P, Averna M, Arca M.

J Clin Lipidol. 2017 Sep - Oct;11(5):1234-1242. doi: 10.1016/j.jacl.2017.06.013. Epub 2017 Jun 24.

PMID:
28733173
37.

Allergic contact dermatitis to acrylates.

Romita P, Foti C, Masciopinto L, Nettis E, Di Leo E, Calogiuri G, Bonamonte D, Angelini G, Dipalma G, Ballini A, Inchingolo F.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):529-534.

PMID:
28685563
38.

Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy.

Maretti E, Costantino L, Rustichelli C, Leo E, Croce MA, Buttini F, Truzzi E, Iannuccelli V.

Int J Pharm. 2017 Aug 7;528(1-2):440-451. doi: 10.1016/j.ijpharm.2017.06.045. Epub 2017 Jun 15.

PMID:
28624659
39.

Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.

Truzzi E, Bongio C, Sacchetti F, Maretti E, Montanari M, Iannuccelli V, Vismara E, Leo E.

Molecules. 2017 Jun 9;22(6). pii: E963. doi: 10.3390/molecules22060963.

40.

High-content drug screening for rare diseases.

Bellomo F, Medina DL, De Leo E, Panarella A, Emma F.

J Inherit Metab Dis. 2017 Jul;40(4):601-607. doi: 10.1007/s10545-017-0055-1. Epub 2017 Jun 7. Review.

PMID:
28593466
41.

Mitochondrial acclimation potential to ocean acidification and warming of Polar cod (Boreogadus saida) and Atlantic cod (Gadus morhua).

Leo E, Kunz KL, Schmidt M, Storch D, Pörtner HO, Mark FC.

Front Zool. 2017 Apr 14;14:21. doi: 10.1186/s12983-017-0205-1. eCollection 2017.

42.

FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.

Mancini M, Castagnetti F, Soverini S, Leo E, De Benedittis C, Gugliotta G, Rosti G, Bavaro L, De Santis S, Monaldi C, Martelli M, Santucci MA, Cavo M, Martinelli G.

J Cell Biochem. 2017 Nov;118(11):3968-3975. doi: 10.1002/jcb.26052. Epub 2017 May 30.

PMID:
28401599
43.

Hypersensitivity reactions due to black henna tattoos and their components: are the clinical pictures related to the immune pathomechanism?

Calogiuri G, Di Leo E, Butani L, Pizzimenti S, Incorvaia C, Macchia L, Nettis E.

Clin Mol Allergy. 2017 Apr 10;15:8. doi: 10.1186/s12948-017-0063-6. eCollection 2017. Review.

44.

Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.

Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, Amin S, Molin MD, Ying H, Kwong LN, Colla S, Takahashi K, Ghosh P, Giuliani V, Muller F, Dey P, Jiang S, Garvey J, Liu CG, Zhang J, Heffernan TP, Toniatti C, Fleming JB, Goggins MG, Wood LD, Sgambato A, Agaimy A, Maitra A, Roberts CW, Wang H, Viale A, DePinho RA, Draetta GF, Chin L.

Nature. 2017 Feb 16;542(7641):362-366. doi: 10.1038/nature21064. Epub 2017 Feb 8.

PMID:
28178232
45.

Direct Patterning of Colloidal Quantum-Dot Thin Films for Enhanced and Spectrally Selective Out-Coupling of Emission.

Prins F, Kim DK, Cui J, De Leo E, Spiegel LL, McPeak KM, Norris DJ.

Nano Lett. 2017 Mar 8;17(3):1319-1325. doi: 10.1021/acs.nanolett.6b03212. Epub 2017 Jan 31.

46.

MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.

Bozzi F, Mogavero A, Varinelli L, Belfiore A, Manenti G, Caccia C, Volpi CC, Beznoussenko GV, Milione M, Leoni V, Gloghini A, Mironov AA, Leo E, Pilotti S, Pierotti MA, Bongarzone I, Gariboldi M.

J Exp Clin Cancer Res. 2017 Jan 23;36(1):16. doi: 10.1186/s13046-016-0475-z.

47.

Abdominosacral resection for locally recurring rectal cancer.

Belli F, Gronchi A, Corbellini C, Milione M, Leo E.

World J Gastrointest Surg. 2016 Dec 27;8(12):770-778. doi: 10.4240/wjgs.v8.i12.770.

48.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP.

Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13.

PMID:
27958281
49.

Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones?

Sacchetti F, D'Arca D, Genovese F, Pacifico S, Maretti E, Hanuskova M, Iannuccelli V, Costi MP, Leo E.

Drug Dev Ind Pharm. 2017 Mar;43(3):465-473. doi: 10.1080/03639045.2016.1262870. Epub 2016 Dec 26.

PMID:
27885848
50.

Effects of ocean acidification increase embryonic sensitivity to thermal extremes in Atlantic cod, Gadus morhua.

Dahlke FT, Leo E, Mark FC, Pörtner HO, Bickmeyer U, Frickenhaus S, Storch D.

Glob Chang Biol. 2017 Apr;23(4):1499-1510. doi: 10.1111/gcb.13527. Epub 2016 Nov 1.

PMID:
27718513

Supplemental Content

Support Center